Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up. The vaccine still remains under emergency use authorization for children 12 ...
Infants and children aged 6 through 23 months have an increased risk for severe COVID-19. The American Academy of Pediatrics (AAP) has updated its COVID-19 vaccination recommendations for preventing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results